Proto Labs Inc
PRLB NYSE· Fabricated Structural Metal Products
Last close · Oct 27, 2026
$89.41
KIRA · Stoqly’s AI analyst, in plain words
- Proto Labs Inc had $533M of revenue in fiscal 2025, up 6.4% on the year before. Over five years, revenue changed +4.2% a year on average.
- Its operating margin was 4.7%, up 0.7 pts: of every 100 in sales, about 5 is left after running the business.
- Proto Labs Inc made $21.2M of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew −6.5% a year.
- Free cash flow was $59.7M in fiscal 2025, 11.2% of revenue.
- Proto Labs Inc returned $43.0M to shareholders in fiscal 2025, 72% of free cash flow. The diluted share count fell 3.8%.
Market cap
$2.2B
P/E
71.5x
Revenue
$533M
Net income
$21.2M
Free cash flow
$59.7M
Operating margin
4.7%
Proto Labs Inc in 30 seconds · fiscal 2025
Are sales growing?
+6.4%
Yes. Sales grew 6.4% last year.
Does it make a profit?
4.0%
A little. It keeps 4.0% of every sale as profit.
Does profit turn into cash?
11.2%
Yes. 11.2% of sales ends up as free cash.
How healthy are the accounts?
6 / 8
Mixed. It passes 6 of 8 health tests.
How is the share priced?
71.5x
One share costs 71.5 times its yearly profit per share.
What Proto Labs Inc does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 20, 2026
- Legal name
- Proto Labs Inc
- CIK
- 0001443669
Proto Labs Inc · PRLB
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $488M | $488M | $504M | $501M | $533M |
| Revenue growth | 12.4% | 0.1% | 3.2% | −0.6% | 6.4% |
| Gross margin | 45.6% | 44.1% | 44.1% | 44.6% | 44.5% |
| Operating margin | 8.3% | −20.1% | 5.6% | 4.0% | 4.7% |
| Net income | $33.4M | −$103M | $17.2M | $16.6M | $21.2M |
| Net margin | 6.8% | −21.2% | 3.4% | 3.3% | 4.0% |
| Diluted EPS | $1.21 | −$3.77 | $0.66 | $0.66 | $0.88 |
| Cash | |||||
| Cash from operations | $55.2M | $62.1M | $73.3M | $77.8M | $74.5M |
| Capital expenditure | $34.2M | $21.7M | $28.1M | $9.2M | $14.8M |
| Free cash flow | $21.0M | $40.4M | $45.2M | $68.7M | $59.7M |
| FCF margin | 4.3% | 8.3% | 9.0% | 13.7% | 11.2% |
| Share buybacks | $23.3M | $29.7M | $44.0M | $60.3M | $43.0M |
| Share count change | 2.8% | −0.9% | −4.3% | −3.9% | −3.8% |
| Debt and strength | |||||
| Cash and short-term investments | $77.5M | $80.1M | $103M | $103M | $128M |
| Shareholders' equity | $828M | $698M | $695M | $670M | $674M |
| Current ratio | 3.3x | 2.6x | 4.0x | 3.7x | 3.5x |
| Returns and quality | |||||
| Return on equity | 4.5% | −13.6% | 2.5% | 2.4% | 3.2% |
| Return on tangible equity | 8.6% | −26.4% | 4.4% | 4.4% | 5.6% |
| Piotroski F-score | 3 | 4 | 7 | 7 | 6 |
| Altman Z'' | 11.2 | 8.2 | 12.1 | 12.1 | 10.6 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$3.3M
3 insiders
Of sales under plans
95%
$3.2M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Proto Labs Inc · PRLB
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $89.41 a share, the company is worth $2.2B: 71.5 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0001443669). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.